Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Randomised controlled study of relaxation training.

S Bindemann1, M Soukop, S B Kaye

  • 1Phoenix Cancer Foundation, AMI Ross Hall Hospital, Glasgow, U.K.

European Journal of Cancer (Oxford, England : 1990)
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase I trial outcomes in older patients with advanced solid tumours.

British journal of cancer·2016
Same author

The impact of donor age and endothelial cell density on graft survival following penetrating keratoplasty.

The British journal of ophthalmology·2015
Same author

Complications of hyperglycaemia with PI3K-AKT-mTOR inhibitors in patients with advanced solid tumours on Phase I clinical trials.

British journal of cancer·2015
Same author

The neutrophil-lymphocyte ratio and its utilisation for the management of cancer patients in early clinical trials.

British journal of cancer·2015
Same author

A randomised, placebo-controlled trial of weekly paclitaxel and saracatinib (AZD0530) in platinum-resistant ovarian, fallopian tube or primary peritoneal cancer†.

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same author

Outcome of patients with sarcoma and other mesenchymal tumours participating in phase I trials: a subset analysis of a European Phase I database.

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same journal

Early-onset colorectal cancer across Europe: Burden, mechanisms, and health-system implications.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Clinical urgency of incidental findings in the first year of the 4-IN-THE-LUNG-RUN lung cancer screening program.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Clinically relevant endpoints and quality-of-life outcomes with darolutamide in patients with metastatic hormone-sensitive prostate cancer: Analyses of the phase III ARASENS trial.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Mapping the anatomical landscape of colorectal tumours: Location-specific efficacy of anti-epidermal growth factor receptor antibodies: Pooled analysis of randomised trials.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Left behind but not left alone: Excluded cell populations in the non-small cell lung cancer stroma predict superior long-term overall survival.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Survival outcomes of adjuvant therapy in resected stage III melanoma: Results from a real-life cohort study (TAMARIS).

European journal of cancer (Oxford, England : 1990)·2026
See all related articles

Relaxation training did not significantly reduce anxiety or depression in cancer patients over 12 weeks. Female patients, particularly those not receiving training, reported higher distress levels.

Area of Science:

  • Oncology
  • Psychology
  • Health Psychology

Background:

  • Cancer patients often experience significant psychological distress, including anxiety and depression.
  • Effective coping resources are crucial for improving the quality of life for individuals undergoing cancer treatment.

Purpose of the Study:

  • To evaluate the efficacy of relaxation training as a coping resource for cancer patients.
  • To assess the impact of relaxation training on anxiety, depression, and psychiatric morbidity.

Main Methods:

  • A 12-week randomized controlled trial involving 80 cancer patients (40 in relaxation training, 40 in control).
  • Anxiety, depression, and psychiatric morbidity were measured using established questionnaires and the Effects of Serious Illness (ESI) scale at baseline, 6, and 12 weeks.

Related Experiment Videos

  • Data were analyzed comparing outcomes between the relaxation training and control groups, with subgroup analysis by sex.

    • Main Results:

    • No significant differences in anxiety, depression, or psychiatric morbidity were found between the relaxation training and control groups at study completion.
    • All patients reported increased distress at 6 and 12 weeks, with women experiencing greater increases.
    • Female patients in the control group consistently reported significantly higher distress scores at 6 and 12 weeks compared to the training group.
    • Male patients in the control group reported significantly higher anxiety scores at 6 and 12 weeks.

    Conclusions:

    • Relaxation training, as implemented in this study, did not demonstrate a significant benefit in reducing psychological distress for cancer patients over 12 weeks.
    • Cancer patients, especially women, are vulnerable to psychological distress, highlighting the need for further research into effective interventions.
    • Sex-based differences in distress levels and response to interventions warrant further investigation in cancer patient populations.